Paradigm Biopharmaceuticals Limited Stock Performance

Paradigm Biopharmaceutica Relative Risk vs. Return Landscape

If you would invest  28.00  in Paradigm Biopharmaceuticals Limited on November 13, 2025 and sell it today you would lose (5.00) from holding Paradigm Biopharmaceuticals Limited or give up 17.86% of portfolio value over 90 days. Paradigm Biopharmaceuticals Limited is currently producing negative expected returns and takes up 5.86% volatility of returns over 90 trading days. Put another way, 52% of traded pink sheets are less volatile than Paradigm, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.Assuming the 90 days horizon Paradigm Biopharmaceutica is expected to under-perform the market. In addition to that, the company is 7.53 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

Paradigm Biopharmaceutica Target Price Odds to finish over Current Price

Assuming the 90 days horizon the pink sheet has the beta coefficient of 1.39 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Paradigm Biopharmaceutica will likely underperform. Additionally Paradigm Biopharmaceuticals Limited has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Paradigm Biopharmaceutica

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Paradigm Biopharmaceutica. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.01 0.23 6.09 Details

Intrinsic Valuation Low Real High 0.01 0.20 6.06 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Paradigm Biopharmaceutica. Your research has to be compared to or analyzed against Paradigm Biopharmaceutica's peers to derive any actionable benefits. When done correctly, Paradigm Biopharmaceutica's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Paradigm Biopharmaceutica.

Paradigm Biopharmaceutica Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Paradigm Biopharmaceutica is not an exception. The market had few large corrections towards the Paradigm Biopharmaceutica's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Paradigm Biopharmaceuticals Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Paradigm Biopharmaceutica within the framework of very fundamental risk indicators.

Paradigm Biopharmaceutica Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Paradigm Biopharmaceutica for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Paradigm Biopharmaceutica can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Paradigm Biopharmaceutica Fundamentals Growth

When running Paradigm Biopharmaceutica's price analysis, check to measure Paradigm Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Paradigm Biopharmaceutica is operating at the current time. Most of Paradigm Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Paradigm Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Paradigm Biopharmaceutica's price. Additionally, you may evaluate how the addition of Paradigm Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.